Acute Lymphoblastic Leukemia

Inherited GATA3 Variant rs38245662 Influences Response to Treatment in Childhood ALL
October 10, 2020

The inherited GATA3 variant rs3824662 was found to strongly influence response to remission induction therapy in childhood acute lymphoblastic leukemia and was also associated with relapse.

Study Supports Use of HSCT in Certain Children & Adolescents with Nonremission ALL
October 09, 2020

Researchers suggested that a scoring system may aid in determining the appropriate use of HSCT in this patient population.

Distance to Treatment Center May Affect Survival for Children and Young Adults with ALL
September 28, 2020

According to researchers, this “group represents more than 20% of children and young adults with ALL, and an increase in attention to adherence, supportive care, and logistics for patients living [more than 50] miles from their treatment center is warranted.”